Using Spotfire DecisionSite to Realize the Full Value of High-Throughput Screening ADME Data Eric Milgram Pfizer Global Research & Development – La Jolla.

Slides:



Advertisements
Similar presentations
The Role of Drug Metabolism Studies in Optimizing Drug Candidates
Advertisements

PhysChem Forum, 29 Nov 2006, Newhouse 1 Memories and the future: From experimental to in silico physical chemistry Han van de Waterbeemd AstraZeneca, DMPK.
Modern Tools for Drug Discovery NIMBUS Biotechnology Modern Tools for Drug Discovery
Improving Candidate Quality Through the Prediction of Clinical Outcome.
Medicinal chemistry Chapter 13 New Methods and Techniques.
December 14, FDA Advisory Committee for Pharmaceutical Science Nonclinical Studies Subcommittee Efficient advancement to clinical trials Jack A.
Pharmacokinetics (PK) ®The study of the disposition of a drug ®The disposition of a drug includes the processes of ADME -  Absorption  Distribution.
Tam Nguyen November 25, 2014 CHEM4201.  Introduction  What is prodrug?  Why use prodrugs?  Classification of prodrugs  Applications of prodrugs 
Drug Fate. Removing substances from the body Some substances are very difficult to eliminate – heavy metals such as lead and mercury The body very efficient.
DISTRIBUTION The body is a container in which a drug is distributed by blood (different flow to different organs) - but the body is not homogeneous. Factors.
Principles of Pharmacology. SOURCES AND NAMES OF DRUGS Sources of Drugs Many drugs are isolated from plants or chemically derived from plant substances.
Metabolism of Xenobiotics I. General Overview Aug 25, 2011 L.M. Ball Rosenau 158 ENVR/TOXC 442 Fall 2011.
Value of in vitro assays in your REACH dossier Frédérique van Acker 18 November 2014.
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Regulatory Requirement on Dossier of Medicinal.
Drug discovery and development
Guidance for Industry M4S: The CTD-Safety
Pharmacokinetics: Bioavailability Asmah Nasser, M.D.
Development of a drug Based on: a known active drug known receptor known endogenous ligand Of natural origin: microorganisms Plants Animals.
Structure-Activity-Relationships (SAR’s) Once a lead has been discovered, it is important to understand precisely which structural features are responsible.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Virtual Drug Development in Southern California, A Pre-Clinical Focus in vitro tests to support IND submissions David Johnson, Ph.D. Director, DMPK MicroConstants,
ERT 420 BIOPHARMACEUTICAL ENGINEERING Semester 1 Academic Session 2012/2013 HUZAIRY HASSAN School Of Bioprocess Engineering Universiti Malaysia Perlis.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Forensic Science Ch. 6 Toxicology ToxicologyAlcohol Testing for Alcohol Role of Toxicologist
ADME And PHARMACOKINETICS.
Exploratory IND Studies
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
PHARMACOKINETICS.
Concepts and Applications of Pharmacokinetics
FARMAKOKINETIKA. INTRODUCTION Historically, pharmaceutical scientists have evaluated the relative drug availability to the body in vivo after giving a.
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
PHARMACOKINETICS Part 3.
Privacy Symposium / HIPAA Summit
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
DuPont Pharmaceuticals Company Utilization of Spotfire™ in Quality Assessment & Analysis of Screening Data Thomas D.Y. Chung, Ph.D. Sr. Director, Leads.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
PHARMACEUTICS- IV (PHT 414 ) Dr. Mohammad Khalid Anwer SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L111/16/2016.
European Patients’ Academy on Therapeutic Innovation Non-clinical development.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
Pharmacology I BMS 242 Lecture 4 Pharmacokienetic Principles (3&4): Drug Metabolism and Excretion [Elimination] Dr. Aya M. Serry 2016.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Foundation Knowledge and Skills
METABOLISME DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA dr. Yunita Sari Pane.
Pharmaceutical Approaches to Antiviral Drug Discovery
Advantages of Good Drug-like Properties 손한표.
독성학 박 대 훈 한약재산업학과
Synthetic Chemistry for the Life Sciences Dial – a – Molecule Workshop, University of Liverpool Jan-12 Where / how can chemistry make greater contribution.
Pharmacokinetics Drug molecules interact with target sites to affect the nervous system –The drug must be absorbed into the bloodstream and then carried.
Chapter 3 PHARMACOKINETICS “What the body does to the drug” Lei Wang
Chapter 5 Drug Metabolism
Drug Discovery &Development
Introduction of Biopharmaceutics & Pharmacokinetics
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Understanding the Basics of Pharmacology
ADME/Tox PredictionTox Prediction. The characterization of Absorption, Distribution, Metabolism, and Excretion (also known as ADME) and Toxicity are essential.
Biopharmaceutics Dr Mohammad Issa Saleh.
PHARMACY TECHNICIAN CHAPTER NINETEEN.
Pharmacologic Principles – Chapter 2
Pharmacokinetics: Metabolism of Drugs
CTD Module 4: Non-Clinical Studies SPC Relevant Scientific information
Insight into the Pharmaceutical Industry
Drug Delivery Systems Pharmaceutical technology Petra University.
Xenobiotic or Drug Metabolism
Three major barriers to the integration of metagenomics into pharmacology and toxicology. Three major barriers to the integration of metagenomics into.
Biopharmaceutics and pharmacokinetic by: Anjam Hama A. M. Sc
Pharmacokinetics/Pharmacodynamics
Presentation transcript:

Using Spotfire DecisionSite to Realize the Full Value of High-Throughput Screening ADME Data Eric Milgram Pfizer Global Research & Development – La Jolla Spotfire Users’ Group Meeting Wednesday October 15, 2003 San Francisco, California Eric Milgram Pfizer Global Research & Development – La Jolla Spotfire Users’ Group Meeting Wednesday October 15, 2003 San Francisco, California

Challenge faced by Pharmaceutical Industry  Reduce Attrition  Increase Productivity  No growth  Budgetary Pressure  Reduce Attrition  Increase Productivity  No growth  Budgetary Pressure Source: PhRMA annual survey, 2000 Cost and Number of NDAs per year

Why Do Candidates Fail? Drug Discovery Today 2:436, NCEs Pharmacokinetics 39% 30% 11% 10% 5% Lack of Efficacy Animal Toxicity Adverse effects in man Miscellaneous Commercial Reasons

The Fate of a Medication after Administration ADME Absorption The movement of drugs into the bloodstream or lymphatic system from the site of administration Distribution The distribution of absorbed drugs from the absorption site to all areas of the body Metabolism The biotransformation of drugs to more polar forms (hydrolysis, oxidation, conjugation, etc.) Excretion The elimination of “unwanted” substances

Drug Metabolism in Drug Discovery Early assessment is critical, since the duration of action is dependent on structural modifications induced by in vivo metabolizing systems. Early knowledge of metabolic products permits metabolism guided structure modification schemes, such as modification of metabolic “soft spots” to achieve prolonged drug action. Identify pharmacologically or toxicologically active metabolites.

Physicochemical & Biochemical In- Vitro Assays Solution Properties Solubility Log D Protein Binding pKa Absorption PAMPA Caco-2, MDCK P gp transport IAM Metabolism Metabolic stability Liver microsomes, S-9, hepatocytes Metabolic profile CYP450 enzyme inhibition Safety Assessment Cell viability Mutagenesis (Ames) Glutathione level Dofetilide binding Predictive of In-Vivo Absorption, Distribution, Metabolism, Excretion

Pritchard, et al., “Making Better Drugs: Decision Gates in Non-Clinical Drug Development” Nature Reviews: Drug Discovery, 2003, vol 2(7), pp (

Advances in Laboratory Robotics and Instrumentation Have Been Swift

Difficulties Resulting from HTS  The rate at which we can collect data far exceeds our capacity to transform this data into information that can be used most effectively to drive important business decisions  Relevance of data?  Number of data dimensions?  What do we do when two different dimensions are in conflict?  Unmasking subtleties (ie “data-mining”)  The rate at which we can collect data far exceeds our capacity to transform this data into information that can be used most effectively to drive important business decisions  Relevance of data?  Number of data dimensions?  What do we do when two different dimensions are in conflict?  Unmasking subtleties (ie “data-mining”)

Visualization is a Powerful Tool For Data Analysis

Spotfire can be used to find trends related to how samples are formatted on plates.

How do we use Spotfire DecisionSite to Allocate Resources Efficiently?  Quality Control and Quality Assurance  Results Analysis and Trending  Quality Control and Quality Assurance  Results Analysis and Trending

When combined with chemometrics techniques, such as principal components analysis (PCA), Spotfire enables viewing of interesting trends in large, multidimensional data sets. STABLE HLM STABLE RHEP STABLE RLM UNSTABLE RHEP UNSTABLE RLM UNSTABLE HLM

Spotfire enables viewing of trends that would be difficult to spot otherwise

Summary  Spotfire DecisionSite enables powerful interrogation of large data sets  Ability to generate quickly new views of the same dataset is essential in a high-throughput discovery environment  Sometimes, weaknesses in experiment design are uncovered  Having a collection of “standard” visualizations greatly facilitates QA  Integration of chemometrics tools (e.g. clustering, PCA, etc) enables researchers to “gain a deeper understanding of their data” (Data  Information)  Spotfire DecisionSite enables powerful interrogation of large data sets  Ability to generate quickly new views of the same dataset is essential in a high-throughput discovery environment  Sometimes, weaknesses in experiment design are uncovered  Having a collection of “standard” visualizations greatly facilitates QA  Integration of chemometrics tools (e.g. clustering, PCA, etc) enables researchers to “gain a deeper understanding of their data” (Data  Information)